FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3086482022> ?p ?o ?g. }

• W3086482022 endingPage "112" @default.
• W3086482022 startingPage "104" @default.
• W3086482022 abstract "Cancer-associated mutations have the potential to generate neoantigens and elicit CD8-positive T-cell-dependent adaptive immune responses. There are currently no reports of CD8-positive T-cells with specificity for neoepitopes generated by EGFR mutations, which are driver oncogenes in a subset of patients with lung cancer.We used NETMHCpan 4.0 to identify putative protective human leukocyte antigen (HLA) class I allotypes that are predicted in silico to bind and present mutant EGFR-generated peptides on the basis of predefined criteria. We associated the presence or absence of these alleles with clinical outcomes in patients from The Cancer Genome Atlas with lung adenocarcinoma.We identified 12 HLA class I alleles that fulfilled the predefined criteria for being protective for EGFR p.L858R and six for EGFR p.E746_A750del, the two most common EGFR mutations in lung cancer. We validated the in silico predictions for peptide-HLA allele binding in vitro. A third (12 of 36) of patients with mostly early stage lung adenocarcinoma in The Cancer Genome Atlas with either EGFR p.L858R or EGFR p.E746_A750del had at least one protective allele in their host genomes. More importantly, patients with protective alleles exhibited better disease-free (hazard ratio: 0.20, 95% confidence interval: 0.05-0.78) and overall survival (hazard ratio: 0.13, 95% confidence interval: 0.02-0.64), and this effect was independent of the EGFR mutation type, stage, age, and sex.Our data revealed that clinical outcomes were improved in patients with EGFR mutation-positive lung adenocarcinoma who harbored protective HLA class I alleles. Thus, immunity with specificity for mutant EGFR is possible in a subset of patients with early stage lung cancer and portends a better prognosis." @default.
• W3086482022 created "2020-09-21" @default.
• W3086482022 creator A5002934250 @default.
• W3086482022 creator A5010966529 @default.
• W3086482022 creator A5025812799 @default.
• W3086482022 creator A5034705456 @default.
• W3086482022 creator A5037285448 @default.
• W3086482022 creator A5073550585 @default.
• W3086482022 date "2021-01-01" @default.
• W3086482022 modified "2023-10-15" @default.
• W3086482022 title "HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival" @default.
• W3086482022 cites W1927635887 @default.
• W3086482022 cites W1969057879 @default.
• W3086482022 cites W2008633460 @default.
• W3086482022 cites W2041553413 @default.
• W3086482022 cites W2041992600 @default.
• W3086482022 cites W2044833878 @default.
• W3086482022 cites W2074631079 @default.
• W3086482022 cites W2114843025 @default.
• W3086482022 cites W2123169315 @default.
• W3086482022 cites W2131876608 @default.
• W3086482022 cites W2134182833 @default.
• W3086482022 cites W2140235037 @default.
• W3086482022 cites W2149441684 @default.
• W3086482022 cites W2159404298 @default.
• W3086482022 cites W2168688111 @default.
• W3086482022 cites W2180481128 @default.
• W3086482022 cites W2326870000 @default.
• W3086482022 cites W2528582910 @default.
• W3086482022 cites W2559953355 @default.
• W3086482022 cites W2597129987 @default.
• W3086482022 cites W2686732860 @default.
• W3086482022 cites W2755026592 @default.
• W3086482022 cites W2769896725 @default.
• W3086482022 cites W2774712455 @default.
• W3086482022 cites W2784995911 @default.
• W3086482022 cites W2795989238 @default.
• W3086482022 cites W2796207838 @default.
• W3086482022 cites W2809081408 @default.
• W3086482022 cites W2890016602 @default.
• W3086482022 cites W2891436740 @default.
• W3086482022 cites W2895264449 @default.
• W3086482022 cites W2911188335 @default.
• W3086482022 cites W2953065444 @default.
• W3086482022 cites W2967717440 @default.
• W3086482022 cites W4237687615 @default.
• W3086482022 doi "https://doi.org/10.1016/j.jtho.2020.08.023" @default.
• W3086482022 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7797166" @default.
• W3086482022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32927123" @default.
• W3086482022 hasPublicationYear "2021" @default.
• W3086482022 type Work @default.
• W3086482022 sameAs 3086482022 @default.
• W3086482022 citedByCount "5" @default.
• W3086482022 countsByYear W30864820222021 @default.
• W3086482022 countsByYear W30864820222023 @default.
• W3086482022 crossrefType "journal-article" @default.
• W3086482022 hasAuthorship W3086482022A5002934250 @default.
• W3086482022 hasAuthorship W3086482022A5010966529 @default.
• W3086482022 hasAuthorship W3086482022A5025812799 @default.
• W3086482022 hasAuthorship W3086482022A5034705456 @default.
• W3086482022 hasAuthorship W3086482022A5037285448 @default.
• W3086482022 hasAuthorship W3086482022A5073550585 @default.
• W3086482022 hasBestOaLocation W30864820221 @default.
• W3086482022 hasConcept C104317684 @default.
• W3086482022 hasConcept C121608353 @default.
• W3086482022 hasConcept C126322002 @default.
• W3086482022 hasConcept C143998085 @default.
• W3086482022 hasConcept C147483822 @default.
• W3086482022 hasConcept C167672396 @default.
• W3086482022 hasConcept C180754005 @default.
• W3086482022 hasConcept C188280979 @default.
• W3086482022 hasConcept C203014093 @default.
• W3086482022 hasConcept C207103383 @default.
• W3086482022 hasConcept C2776256026 @default.
• W3086482022 hasConcept C2781182431 @default.
• W3086482022 hasConcept C44249647 @default.
• W3086482022 hasConcept C502942594 @default.
• W3086482022 hasConcept C54355233 @default.
• W3086482022 hasConcept C71924100 @default.
• W3086482022 hasConcept C86803240 @default.
• W3086482022 hasConcept C8891405 @default.
• W3086482022 hasConceptScore W3086482022C104317684 @default.
• W3086482022 hasConceptScore W3086482022C121608353 @default.
• W3086482022 hasConceptScore W3086482022C126322002 @default.
• W3086482022 hasConceptScore W3086482022C143998085 @default.
• W3086482022 hasConceptScore W3086482022C147483822 @default.
• W3086482022 hasConceptScore W3086482022C167672396 @default.
• W3086482022 hasConceptScore W3086482022C180754005 @default.
• W3086482022 hasConceptScore W3086482022C188280979 @default.
• W3086482022 hasConceptScore W3086482022C203014093 @default.
• W3086482022 hasConceptScore W3086482022C207103383 @default.
• W3086482022 hasConceptScore W3086482022C2776256026 @default.
• W3086482022 hasConceptScore W3086482022C2781182431 @default.
• W3086482022 hasConceptScore W3086482022C44249647 @default.
• W3086482022 hasConceptScore W3086482022C502942594 @default.
• W3086482022 hasConceptScore W3086482022C54355233 @default.
• W3086482022 hasConceptScore W3086482022C71924100 @default.
• W3086482022 hasConceptScore W3086482022C86803240 @default.

• next